- Home
- MXE vs BEAT Comparison
MXE vs BEAT Comparison
Compare MXE & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MXE | BEAT |
|---|---|---|
| Founded | 1990 | 2015 |
| Country | United States | United States |
| Employees | N/A | 16 |
| Industry | Finance Companies | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.9M | 53.2M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | MXE | BEAT |
|---|---|---|
| Price | $13.42 | $0.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 2.2K | ★ 561.5K |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $315.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.05 | $0.54 |
| 52 Week High | $14.30 | $4.00 |
Technical Indicators
Market Signals| Indicator | MXE | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 50.53 | 30.59 |
| Support Level | $12.80 | $0.54 |
| Resistance Level | $14.17 | $0.94 |
| Average True Range (ATR) | 0.32 | 0.05 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 70.10 | 7.20 |
Price Performance
Historical ComparisonAbout MXE Mexico Equity and Income Fund Inc. (The)
Mexico Equity and Income Fund Inc. is a closed-end, non-diversified management investment company that aims for long-term capital appreciation and current income. It prominently invests in equity, convertible securities, and debt issued by Mexican companies, operating across various sectors. The fund benchmarks its performance against the Mexbol and MSCI Mexico Index. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.